Patient-reported outcomes of brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma

by Chen R, Allibone S, Bartlett NL, Brice P, Chen A, Pose K, Rich L, Bonthapally V, Garfin PM, Fanale M
Published 2016-04-01

US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology...

by Press, O. W., Li, H., Schoder, H., Straus, D. J., Moskowitz, C. H., LeBlanc, M., Rimsza, L. M., Bartlett, N. L., Evens, A. M., Mittra, E. S., LaCasce, A. S., Sweetenham, J. W., Barr, P. M., Fanale, M. A., Knopp, M. V., Noy, A., Hsi, E. D., Cook, J. R., Lechowicz, M. J., Gascoyne, R. D., Leonard, J. P., Kahl, B. S., Cheson, B. D., Fisher, R. I., Friedberg, J. W.
Published 2016